A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

NCT03486912 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Cirrhosis
Liver Fibrosis
Nonalcoholic Fatty Liver Disease (NAFLD)
Nonalcoholic Steatohepatitis

Interventions

DRUG: BMS-986036
OTHER: Placebo

Sponsor

Bristol-Myers Squibb